VANCOUVER, BC / ACCESSWIRE / February 27, 2017 / Canamex Resources Corp. (TSX-V: CSQ) (OTC PINK: CNMXF) (FSE: CX6) (the “Company”) announces the grant on February 24, 2017 of options entitling eligible participants to purchase an aggregate of 1,275,000 common shares, exercisable in whole or in part on or before February 23, 2022 at an exercise price of $0.16 per share. These options were issued pursuant to the Company’s 10% Rolling Stock Option Plan (the “Plan”) that was last approved by shareholders December 29, 2015 and accepted for filing by the TSX Venture Exchange on January 26, 2016.

ON BEHALF OF THE BOARD

SIGNED: “Mark Billings”

Mark Billings, CEO and Director
Contact: (514) 296-1641, mbillings@canamex.us

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Canamex Resources Corp.

ReleaseID: 456099

LOS ANGELES, CA / ACCESSWIRE / February 27, 2017 / Stony Hill Corp. (OTCQB: STNY), a diversified company focused on the cannabis industry, announced today that it has entered into an asset purchase agreement with mCig., Inc. (OTCQB: MCIG). The parties have entered into an asset purchase agreement for the purpose of pursuing mutually beneficial business opportunities in the Cannabidiol (CBD) Industry.

Under the terms of the agreement, mCig, Inc. will sell the VitaCBD brand to Stony Hill Corp., in exchange for total consideration of $850,000 in cash and common stock, and a 20% stake in VitaCBD, LLC, a subsidiary of STNY.

Paul Rosenberg, President and CEO of MCIG, commented, “MCIG has worked diligently to build the VitaCBD product line, but recognizes the need for a strategic partner to assist in branding and marketing of the product line. After months of discussions and negotiations, we believe we have found that partner with Stony Hill. We are very bullish on the future revenue potential of VitaCBD and its ability to create value for our company and its shareholders.”

VitaCBD is a highly dedicated group devoted to engineering the purest hemp derived products available. Both hemp and cannabis contain dozens of cannabinoids, naturally occurring chemical compounds, but it is cannabidiol (CBD), in particular that offers the potential for health and therapeutic benefits without the high. Hemp plants typically contain elevated levels of health-enhancing CBD, but by definition contain only trace levels of THC. This makes the hemp plant attractive to those seeking its potential health benefits as part of an antioxidant-rich lifestyle.

Chris Bridges, President of Stony Hill, stated, “This transaction will expand the Stony Hill platform of products and accelerate its growth strategy in the industry. Stony Hill and mCig will have a synergistic relationship, combining management and personnel with a dedicated focus on the promotion and deployment of the VitaCBD brand. We are excited to have mCig as a strategic partner and a shareholder in Stony Hill.”

About Stony Hill Corp.

Stony Hill Corp. (www.stonyhillcorp.com) is a diversified company focused on multiples areas of the cannabis, hemp, and CBD industry. The Company is focused on select investment, branding, real estate, and partnership opportunities in the recreational, health and wellness, nutraceutical, and media industries.

Stony Hill has several strategic partnerships currently in place and is actively pursuing additional partnerships and other strategic growth opportunities.

Contact

Email: ir@stonyhillcorp.com or info@stonyhillcorp.com
To be added to the Stony Hill email distribution list, please email info@stonyhillcorp.com with STNY in the subject line.

Follow us on:

Facebook @stonyhillofficial
Instagram @stonyhillofficial
Twitter @stonyhillnews

About the OTCQB Marketplace:

About the OTCQB Marketplace: The OTCQB is a venture stage marketplace for early stage and developing U.S. and international companies. Companies listed on the OTCQB must be current in their reporting and undergo an annual verification and management certification process.

Safe Harbor Statement

Forward-Looking Statements Except for historical information contained herein, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are inherently unreliable and actual results may differ materially. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as the development and protection of our brands and other intellectual property, the need to raise capital to meet business requirements, significant fluctuations in marketing expenses and ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of its products and services, as well as the introduction of competing products, or management’s ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and other information that may be detailed from time to time in the Company’s filings with the United States Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE: Stony Hill Corp.

ReleaseID: 456098

IRVINE, CA / ACCESSWIRE / February 27, 2017 / Khang & Khang LLP (the “Firm”) announces the filing of a class action lawsuit against Under Armour, inc (“Under Armour” or the “Company”) (NYSE: UAA). Investors, who purchased or otherwise acquired shares between April 21, 2016 and January 30, 2017 inclusive (the “Class Period”), are encouraged to contact the Firm in advance of the April 10, 2017 lead plaintiff motion deadline.

If you purchased shares of Under Armour during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

On January 31, 2017, Under Armour announced unsatisfactory fourth-quarter revenues and announced CFO, Chip Molloy, would be resigning. About $2.7 billion of Under Armour’s market capitalization vanished on January 31, 2017 after the Company stated its quarterly revenue growth fell sharply.

When this information was disclosed to the public, the value of Under Armour declined, causing investors serious harm.

If you wish to learn more about this lawsuit, at no charge, or if you have questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact:

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 456093

IRVINE, CA / ACCESSWIRE / February 27, 2017 / Khang & Khang LLP (the “Firm”) announces the filing of a class action lawsuit against FXCM, Inc. (“FXCM” or the “Company”) (NASDAQ: FXCM). Investors, who purchased or otherwise acquired FXCM shares between March 15, 2012 and February 6, 2017 inclusive (the “Class Period”), are encouraged to contact the firm in advance of the April 10, 2017 lead plaintiff deadline.

If you purchased shares of FXCM during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

On February 6, 2017, the U.S. Commodity Futures Trading Commission stopped FXCM from operating in the U.S. When this news was announced to the investing public, the value of FXCM stock fell, causing investors serious harm.

If you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact:

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 456095

LOS ANGELES, CA / ACCESSWIRE / February 27, 2017 / Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against Stemline Therapeutics, Inc. (“Stemline” or the “Company”) (NASDAQ: STML) concerning possible violations of federal securities laws. Investors, who purchased or otherwise acquired Stemline shares between January 19, 2017 and February 1, 2017 inclusive (the “Class Period”), are encouraged to contact the firm in advance of the April 4, 2017 lead plaintiff deadline.

To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

On February 2, 2017, Bloomberg confirmed that a patient undergoing a clinical trial of Stemline’s cancer drug SL-401 died from a severe side effect, the third death related to SL-401 toxicity.

When this information was revealed to the public, the value of Stemline stock fell sharply, causing investors harm.

Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 456094

LOS ANGELES, CA / ACCESSWIRE / February 27, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Roadrunner Transportation Systems Inc. (“Roadrunner” or the “Company”) (NYSE: RRTS). Investors, who purchased or otherwise acquired Roadrunner shares between May 8, 2014 and January 30, 2017 inclusive (the “Class Period”), are encouraged to contact the firm in advance of the April 03, 2017 lead plaintiff deadline.

To participate in this class action lawsuit, click here, or call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

Roadrunner disclosed on January 30, 2017 that its financial statements would need to be edited. The Company attributes the problem to accounting mistakes that Roadrunner anticipates will necessitate changes of $20 million to $25 million. When this information was released to the public, the value of Roadrunner dropped, causing shareholders serious harm.

Lundin Law PC was established by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com

SOURCE: Lundin Law PC

ReleaseID: 456092

HENDERSON, NV / ACCESSWIRE / February 27, 2017 / mCig, Inc. (OTCQB: MCIG), a diversified company focused on the cannabis industry, announced today that it has entered into an asset purchase agreement with Stony Hill Corp. (OTCQB: STNY) for the purpose of pursuing mutually beneficial business opportunities in the Cannabidiol (CBD) Industry. Under terms of the agreement, MCIG will sell the VitaCBD brand to STNY, in exchange for total consideration of $850,000 in cash and common stock, and a 20% stake in VitaCBD, LLC, a subsidiary of STNY.

Paul Rosenberg, President and CEO of MCIG, commented, “MCIG has worked diligently to build the VitaCBD product line, but recognizes the need for a strategic partner to assist in branding and marketing of the product. After months of discussions and negotiations, we believe we have found that partner with Stony Hill. We are very bullish on the future revenue potential of VitaCBD and its ability to create value for our company and its shareholders.”

VitaCBD is a highly dedicated group devoted to engineering the purest hemp derived products available. Both hemp and marijuana contain dozens of cannabinoids, naturally occurring chemical compounds, but it is cannabidiol (CBD), in particular, that offers the potential for health and therapeutic benefits without the high. Hemp plants typically contain elevated levels of health-enhancing CBD, but by definition contain only trace levels of THC. This makes the hemp plant attractive to those seeking its potential health benefits as part of an antioxidant-rich lifestyle.

Chris Bridges, President of STNY, stated, “This transaction will expand Stony Hill’s platform of products and accelerate its growth strategy in the industry. Stony Hill and mCig will have a synergistic relationship, combining management and personnel with a dedicated focus on the promotion and deployment of the VitaCBD brand. We are excited to have mCig as a strategic partner and a shareholder in Stony Hill.”

About mCig, Inc.

Headquartered in Henderson, Nevada, mCig Inc. (OTCQB: MCIG) is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands. MCIG has transitioned from a vaporizer manufacturer to an industry leading, large scale, full service cannabis cultivation construction company, with its Grow Contractors division currently operating in the rapidly expanding Nevada market. The company looks forward to growing its core competencies to service the Ancillary legal Cannabis, Hemp, and CBD markets, with broader expansion to take place once federal laws change. For more information, visit www.mcig.org.

Safe Harbor Statement

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company’s ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company’s products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and the Company’s business, research, product development, regulatory approval, marketing, and distribution plans and strategies.

Contact:

CEO of mCig, Inc.
Paul Rosenberg
paul@mcig.org

SOURCE: mCig, Inc.

ReleaseID: 456047

LOS ANGELES, CA / ACCESSWIRE / February 27, 2017 / Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against Banc of California, Inc. (“Banc of California” or the “Company”) (NYSE: BANC) concerning possible violations of federal securities laws between August 7, 2015 and January 23, 2017 inclusive (the “Class Period”). Investors, who purchased or otherwise acquired shares during the Class Period, should contact the firm prior to the March 24, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

Seeking Alpha released an article claiming that Banc of California had concealed several connections between it and Jason Galanis, who has been convicted of criminal securities fraud. Specifically, the Complaint maintains that: Banc of California CEO Jason Sugarman was the founder, CEO, and indirect owner of a company controlled by Galanis; and that separately, Galanis controlled Banc of California’s founding shareholder. The Complaint further claims that Banc of California was using an off-balance sheet entity to render loans to insiders.

Then, on November 10, 2016, Banc of California revealed it would be stalling the filing of its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2016 so that its Special Committee could complete a review into the aforementioned improper relationships and related party transactions. On January 23, 2017, Banc of California stated that the Securities and Exchange Commission is pursuing a formal order of investigation directed at these same issues.

When this news was released to the public, the value of Banc dropped, causing investors harm.

Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 456084

IRVINE, CA / ACCESSWIRE / February 27, 2017 / Khang & Khang LLP (the “Firm”) announces the filing of a class action lawsuit against Fenix Parts, Inc. (“Fenix” or the “Company”) (NASDAQ: FENX) concerning possible violations of federal securities laws. Investors, who purchased or otherwise acquired Fenix shares between May 14, 2015 and October 12, 2016 inclusive (the “Class Period”), are encouraged to contact the firm in advance of the March 13, 2017 lead plaintiff motion deadline.

If you purchased shares of Fenix during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

According to the Complaint, during the Class Period, Fenix issued false and/or misleading statements and/or failed to disclose: that its inventory valuation tools were inadequate; that its tools to calculate goodwill impairment were poor; that it was engaging and/or had engaged in activity that would lead to an SEC investigation; and that as a result, Fenix’s statements about its business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

When this information was released to the public, the value of Fenix stock fell, causing investors serious harm.

If you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact:

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 456076